Targeting Metastatic Breast Cancers by Alkaline Glucosodiene Molecules Via a Metabolic Pathway Phase I Clinical Trial

NCT05957939 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

2

Enrollment

OTHER_GOV

Sponsor class

Conditions

TNBC - Triple-Negative Breast Cancer

Interventions

DRUG: Alkaline Glucosodiene Molecules

Sponsor

Ministry of Health, Saudi Arabia

Collaborators

[object Object]